NEW YORK, Sept. 28, 2022 — LMG Life Sciences has once again recognized King & Spalding with multiple rankings in the 2022 edition of its guide, which identifies the leading law firms and lawyers serving the life sciences industry.
The guide ranks the firm in the following categories:
- FDA: Medical Device
- FDA: Pharmaceutical
- Hatch-Waxman Patent Litigation (Branded)
- Healthcare: Pricing & Reimbursement
- Licensing & Collaboration
- Product Liability
- White-Collar/Govt. Investigations
In addition, LMG named 21 King & Spalding lawyers “Life Sciences Stars” in various practice areas.
The firm’s full rankings are available here.
About King & Spalding
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,200 lawyers in 23 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.